Our Board of Directors represent the diverse communities within the regenerative medicine movement. Clinic practitioners, researchers, patients, and regulators all share a common goal, but with different visions. Our leadership, including this and our other boards, reflect an example of the larger system working together to bring cohesiveness to these communities, based on our "interests" for patients, rather than our "positions."
Theresa Taylor, Acting Director
Doug Oliver, M.S.W.
Clay Graybeal, Ph.D., M.S.W.
University of New England
David B. Harrell, Ph.D.
Harrell BioScience Consulting, LLC
Keith March, MD, Ph.D.
University of Florida
Dimitry Shvartsman, Ph.D.
Senior Research Manager Harvard Stem Cell Institute
Keith Uselton, CPA/APV
Principal, Uselton, Clay & Bright
Samantha Wilkinson, BS
Patients For Stem Cells